- PrecISE Participant Advisory Council member
You are not alone.
Meet some of the others just like you.
-Photo of a PrecISE Participant Advisory Council (PAC) member.
-Why PrecISE? Better ways to treat severe asthma
-Photo of a PrecISE Participant Advisory Council (PAC) member.
What is Severe Asthma?
Asthma is a long-lasting disease. It affects the airways that carry air in and out of the lungs. The airways can react to such things as dust, pollen, chemicals, or bacteria. Some symptoms of asthma are wheezing, coughing, chest tightness, and trouble breathing. Most people with asthma can control their symptoms with medicine. They can still do their daily activities.
About 10-15% of people with asthma have severe asthma. There are different types of severe asthma. It can start in childhood or later in life. Medicines for asthma that are available right now often don’t work well for people with severe asthma. This disease can make their lives very difficult.
What is PrecISE?
PrecISE is a research study to understand how to treat different types of severe asthma. PrecISE has completed enrollment.
This study is sponsored by the U.S. National Heart, Lung, and Blood Institute.
How PrecISE is Different from Other Severe Asthma Studies
Many studies look only at the patient’s symptoms or lung function for choosing a medicine. But people with severe asthma can be very different from each other. They may have the same symptoms, but different things can be happening in their bodies that cause the same symptoms. This means that the same medicine might not work the same way in different people, even if they have the same symptoms. This is one reason that severe asthma is so hard to treat.
PrecISE has two goals: 1) Research how to more easily identify some of the types of severe asthma. 2) Research treatments for the types of severe asthma being studied in PrecISE.
News and Research
Observing World Asthma Month Every Day in May
There are many organizations providing opportunities for the May 2, 2023 observance of World Asthma Day and World Asthma Month, which is in May each year.
Severe Asthma Clinical Practice Course at ATS 2023
What are the latest recommendations for the management of severe asthma? See details about a post-graduate course being offered at ATS 2023.
Moderate to Severe Asthma: A Podcast Series
A limited podcast series is now available that takes a deep dive into the diagnosis, treatment, and ongoing care of patients with moderate to severe asthma. Produced by Medscape, the “InDiscussion: Moderate to Severe Asthma” podcast series is an in-depth interview style-look at the field of asthma.